<p>OVA-immunized (i.p., day0 and 14) and sensitized (5% aerosolized-OVA, day21 to 25) BALB/c mice were challenged with PBS or rAg85B protein (i.p. (100 µg; days 0 and 14) and i.n. (20 µg; days 21, 23, and 25)). At 24 h after the last OVA sensitization, mediastinal lymph nodes (MLNs) from naïve or OVA sensitized BALB/c mice treated with PBS or rAg85B, were harvested. MLNs were cultured with OVA (50 µg/ml), and cytokines in the culture supernatant were determined 48 h after incubation by ELISA. Data are representative of at least three independent experiments (*P<0.05, **P<0.01 compared with OVA control. error bars, s.d.; n = 6 mice).</p
<p>The levels of cytokines in supernatants of OVA-stimulated mice splenocytes (incubated with OVA fo...
<p>(a–f) Ova stimulated production of IL-17A, IL-4, and IFN-γ by lymphocytes from DLN or spleen of m...
<p>(<b>A</b>) BM-DC were incubated with indicated concentrations of OVA or OVA-Cl for 2 h at 37°C. W...
<p>OVA-immunized (i.p., day0 and 14) and sensitized (5% aerosolized-OVA, day21 to 25) BALB/c mice we...
<p>OVA-immunized (i.p., day0 and 14) and sensitized (5% aerosolized-OVA, day21 to 25) BALB/c mice we...
<p>OVA-immunized (i.p., day0 and 14) and sensitized (5% aerosolized-OVA, day21 to 25) BALB/c mice we...
<p>OVA-immunized (i.p., day0 and 14) and sensitized (5% aerosolized-OVA, day21 to 25) BALB/c mice we...
<p>Experimental design used to investigate the effects of rAg85B on OVA-induced allergic lung inflam...
<p>OVA-sensitized BALB/c mice (5% aerosolized-OVA, day21 to 25) were challenged intranasally with PB...
<p>OVA-sensitized BALB/c mice (5% aerosolized-OVA, day21 to 25) were challenged intranasally with PB...
<p>Cytokine concentrations were measured in the BALF samples (A). The lymphocytes were activated by ...
<p>IFN-γ and IL-17-producing Th cells are induced in regional lymph nodes by rAg85B challenge, howev...
<p>WT or JH-<sup>/-</sup> mice were intranasally exposed to OAAH for 2 weeks, as described in <a hre...
<p>C57BL/6 mice were immunized with OVA co-administered with different adjuvants. Control animals re...
<p>Mice were exposed to 15ppm NO<sub>2</sub> for 1 hour on day 1. All mice were exposed to OVA on da...
<p>The levels of cytokines in supernatants of OVA-stimulated mice splenocytes (incubated with OVA fo...
<p>(a–f) Ova stimulated production of IL-17A, IL-4, and IFN-γ by lymphocytes from DLN or spleen of m...
<p>(<b>A</b>) BM-DC were incubated with indicated concentrations of OVA or OVA-Cl for 2 h at 37°C. W...
<p>OVA-immunized (i.p., day0 and 14) and sensitized (5% aerosolized-OVA, day21 to 25) BALB/c mice we...
<p>OVA-immunized (i.p., day0 and 14) and sensitized (5% aerosolized-OVA, day21 to 25) BALB/c mice we...
<p>OVA-immunized (i.p., day0 and 14) and sensitized (5% aerosolized-OVA, day21 to 25) BALB/c mice we...
<p>OVA-immunized (i.p., day0 and 14) and sensitized (5% aerosolized-OVA, day21 to 25) BALB/c mice we...
<p>Experimental design used to investigate the effects of rAg85B on OVA-induced allergic lung inflam...
<p>OVA-sensitized BALB/c mice (5% aerosolized-OVA, day21 to 25) were challenged intranasally with PB...
<p>OVA-sensitized BALB/c mice (5% aerosolized-OVA, day21 to 25) were challenged intranasally with PB...
<p>Cytokine concentrations were measured in the BALF samples (A). The lymphocytes were activated by ...
<p>IFN-γ and IL-17-producing Th cells are induced in regional lymph nodes by rAg85B challenge, howev...
<p>WT or JH-<sup>/-</sup> mice were intranasally exposed to OAAH for 2 weeks, as described in <a hre...
<p>C57BL/6 mice were immunized with OVA co-administered with different adjuvants. Control animals re...
<p>Mice were exposed to 15ppm NO<sub>2</sub> for 1 hour on day 1. All mice were exposed to OVA on da...
<p>The levels of cytokines in supernatants of OVA-stimulated mice splenocytes (incubated with OVA fo...
<p>(a–f) Ova stimulated production of IL-17A, IL-4, and IFN-γ by lymphocytes from DLN or spleen of m...
<p>(<b>A</b>) BM-DC were incubated with indicated concentrations of OVA or OVA-Cl for 2 h at 37°C. W...